Clinical Trials · NCT02130973
The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- Health Research, Inc.
- Enrollment
- 60
- Start date
- Aug 2013
- Locations
- 1 site, United States
- Primary endpoint
- spine bone density